KalVista Pharmaceuticals, Inc. (KALV)

15.91 +0.60 (+3.92%) USD  |  NASDAQ  |  Jan 21, 16:00
15.74 -0.17 (-1.07%) Pre-Market: 08:57
More

KalVista Pharmaceuticals Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. Upgrade
Silvergate Capital Corp. --
Perspective Therapeutics, Inc. Upgrade
Electromed, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade